No Relief: Rising MS Drug Prices
Episode 7, Feb 11, 2020, 10:00 AM
Welcome to the NeurologyLive Mind Moments podcast.
In this episode, Daniel M. Hartung, PharmD, MPH, associate professor of pharmacy at Oregon State University College of Pharmacy, discusses findings of a report he and colleagues compiled on rising spending in the US Medicaid program on disease-modifying therapies for multiple sclerosis, and the unique nature of their prices in the United States.
For more on MS and other neurology topics, visit NeurologyLive.com. Thanks for listening.